[Workshop] RWE in Regulatory Decision-Making Processes

February 25, 2021

A recent workshop focusing on RWE (real world evidence) explored the role in observational studies in determining drug effectiveness and in seeking FDA approval. Speakers discuss challenges in using RWE and how to identify and address gaps in knowledge. The two-day online workshop took place in mid-February and a recording is available online.

“The conference will explore challenges with data adequacy, bias in observational studies that may impact causal inference, including provider- and patient-based perceptions of the assigned treatment and differential adherence to treatment. Panel discussions will explore how benefits can be realized, identify gaps in knowledge, and consider strategies for addressing those gaps.” Learn more here.

(Source: Duke-Margolis Center for Health Policy, 2/16/21)

Share This Story!